2023
DOI: 10.1158/1535-7163.22522348
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplementary Data from The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in Colorectal Cancer Therapy in a Bim-Dependent Manner

Abstract: <p>contains supplementary figures and tables</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles